Attorney General Pam Bondi News Release
March 26, 2014
Contact: Whitney Ray
Phone: (850) 245-0150

Print Icon Print Version

Attorney General Pam Bondi Asks U.S. Health and Human Services Secretary to Keep Potent Zohydro off Market

TALLAHASSEE, Fla.—After the Food and Drug Administration ignored the plea of 29 attorneys general asking the FDA not to approve the highly potent painkiller Zohydro and to require abuse-deterrent technologies, Attorney General Pam Bondi and four other attorneys general are now imploring U.S. Health and Human Services Secretary Kathleen Sebelius to keep this drug off the market until abuse-deterrent safeguards are implemented. Zohydro ER is a new high-dose opioid painkiller five to ten times more potent than currently available hydrocodone products. Sadly, the nation remains gripped in a prescription drug abuse epidemic, and as recently as 2010, seven Floridians were dying per day due to prescription drug overdoses.

“Because the FDA chose to move forward with putting this extremely potent painkiller on the market—without abuse deterrent safeguards in place—we are now asking that the Health and Human Services Secretary take immediate action to prevent the loss of lives due to overdoses,” stated Attorney General Pam Bondi. “Our nation is facing a prescription drug abuse epidemic, and it is irresponsible to approve such a potent painkiller without abuse-deterrent technologies that can help prevent the crushing of the pills in order to snort or inject them.”

Attorney General Bondi was joined in the letter she sent today to Secretary Sebelius by Indiana Attorney General Gregory Zoeller, Illinois Attorney General Lisa Madigan, Kentucky Attorney General Jack Conway, and Maine Attorney General Janet Mills. To view the letter, please follow this link$file/MarchZohydro.pdf